Fiscal 2027 guidance of $550 million to $560 million leans on $100 million from AI drug discovery customers, a concentration bet investors are repricing right now. Revenue topped estimates and adjusted EBITDA turned positive at $2.2 million, but the wider loss per share missed expectations as SG&A climbed to $74.7 million.
Latest Activity
TWST Coverage
Cathie Wood Is Buying the CoreWeave Dip and Selling Palantir
ARK stepped into a sliding AI infrastructure stock while quietly trimming a premium-priced winner. One date next week could decide whether that bet on debt-fueled growth was savvy or early.
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)
Anthropic is racing toward a public debut in September with a healthcare AI pitch that could ignite a sector most investors are not watching. Five biotech names are already moving, and one…
Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, DuPont, EPAM Systems, Ferrari, Paychex, Rocket Lab, TeraWulf, and More
Pre-Market Stock Futures: Futures are exploding higher on news of a peace deal with Iran expected to be signed this Friday. This follows a historic Friday that saw the coming-out party of…
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More
Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI…
TWST vs. NTRA: Which Genomics Play Is a Better Buy?
Cathie Wood’s Ark funds have been really heating up in recent months. Perhaps her most intriguing and underrated fund is the Ark Genomics Revolution ETF (ARKG), which is packed full of extraordinary…
1 Top Technology ETF to Buy and 1 to Avoid
The technology-oriented Nasdaq 100 index is back into correction territory, down 10.5% after hitting an all-time high last month. The tech sector has been the driving force for the stock market’s gains…
Wednesday’s Top Analyst Upgrades and Downgrades: Amazon, AMC, Apple, CVS, Etsy, Goldman Sachs, PayPal, Tesla, T-Mobile and More
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences, Goldman Sachs, GSK, PayPal, Tesla, T-Mobile, U.S.…
Tuesday’s Top Analyst Upgrades and Downgrades: Carvana, CSX, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and More
Tuesday’s top analyst upgrades and downgrades included Coursera, CSX, Carvana, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and Rackspace.